Cargando…
The change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: Continuous measurement of vital signs using a non‐wearable monitor
OBJECTIVES: The aim of this study was to examine the following by using a non‐wearable monitor: (ⅰ) the trajectory of vital signs (VS) in the last 2 weeks of life among cancer patients, and (ⅱ) the difference in change over time of VS between cancer patients with and without opioid use. METHODS: We...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683542/ https://www.ncbi.nlm.nih.gov/pubmed/34845870 http://dx.doi.org/10.1002/cam4.4382 |
_version_ | 1784617443175432192 |
---|---|
author | Tanaka, Haruka Fukui, Sakiko Maeda, Isseki Hatano, Yutaka Higuchi, Akari Higami, Yoko Yamakawa, Miyae Utsumi, Momoe |
author_facet | Tanaka, Haruka Fukui, Sakiko Maeda, Isseki Hatano, Yutaka Higuchi, Akari Higami, Yoko Yamakawa, Miyae Utsumi, Momoe |
author_sort | Tanaka, Haruka |
collection | PubMed |
description | OBJECTIVES: The aim of this study was to examine the following by using a non‐wearable monitor: (ⅰ) the trajectory of vital signs (VS) in the last 2 weeks of life among cancer patients, and (ⅱ) the difference in change over time of VS between cancer patients with and without opioid use. METHODS: We conducted a longitudinal study involving cancer patients in a palliative care unit (PCU) from April 2018 to October 2019. VS were collected continuously using a non‐wearable monitor, and we calculated the means of respiratory rate (RR) and heart rate (HR) per hour, and counts of apnea per hour as outcome variables. Explanatory variables were time (subtracting time of death from measurement time of VS, divided by 36) and opioid use. Mean difference (MD) of time represented the slope per hour of VS values. First, we analyzed the associations between VS per hour and time using a linear mixed model (LMM) with random intercepts and slope over time. Second, we analyzed the associations between VS and interaction term between time and opioid use. RESULTS: We analyzed 26 cancer patients. RR (MD: 0.27 beats/min [95% CI: 0.27–0.28]), HR (MD: 1.51 beats/min [95% CI: 1.50–1.52]), and apnea (MD: 0.71 count/hour [95% CI: 0.70–0.72]) significantly increased hourly. In addition, RR was significantly associated with interaction term (MD: −1.59 beats/min [95% CI: −3.11 to −0.07]), which indicates that there is a difference in the slope of RR between opioid users and non‐users. CONCLUSIONS: We have successfully described the trajectory of VS in high‐resolution under conditions of a natural end of life in PCU. |
format | Online Article Text |
id | pubmed-8683542 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86835422021-12-30 The change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: Continuous measurement of vital signs using a non‐wearable monitor Tanaka, Haruka Fukui, Sakiko Maeda, Isseki Hatano, Yutaka Higuchi, Akari Higami, Yoko Yamakawa, Miyae Utsumi, Momoe Cancer Med Clinical Cancer Research OBJECTIVES: The aim of this study was to examine the following by using a non‐wearable monitor: (ⅰ) the trajectory of vital signs (VS) in the last 2 weeks of life among cancer patients, and (ⅱ) the difference in change over time of VS between cancer patients with and without opioid use. METHODS: We conducted a longitudinal study involving cancer patients in a palliative care unit (PCU) from April 2018 to October 2019. VS were collected continuously using a non‐wearable monitor, and we calculated the means of respiratory rate (RR) and heart rate (HR) per hour, and counts of apnea per hour as outcome variables. Explanatory variables were time (subtracting time of death from measurement time of VS, divided by 36) and opioid use. Mean difference (MD) of time represented the slope per hour of VS values. First, we analyzed the associations between VS per hour and time using a linear mixed model (LMM) with random intercepts and slope over time. Second, we analyzed the associations between VS and interaction term between time and opioid use. RESULTS: We analyzed 26 cancer patients. RR (MD: 0.27 beats/min [95% CI: 0.27–0.28]), HR (MD: 1.51 beats/min [95% CI: 1.50–1.52]), and apnea (MD: 0.71 count/hour [95% CI: 0.70–0.72]) significantly increased hourly. In addition, RR was significantly associated with interaction term (MD: −1.59 beats/min [95% CI: −3.11 to −0.07]), which indicates that there is a difference in the slope of RR between opioid users and non‐users. CONCLUSIONS: We have successfully described the trajectory of VS in high‐resolution under conditions of a natural end of life in PCU. John Wiley and Sons Inc. 2021-11-29 /pmc/articles/PMC8683542/ /pubmed/34845870 http://dx.doi.org/10.1002/cam4.4382 Text en © 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Cancer Research Tanaka, Haruka Fukui, Sakiko Maeda, Isseki Hatano, Yutaka Higuchi, Akari Higami, Yoko Yamakawa, Miyae Utsumi, Momoe The change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: Continuous measurement of vital signs using a non‐wearable monitor |
title | The change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: Continuous measurement of vital signs using a non‐wearable monitor |
title_full | The change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: Continuous measurement of vital signs using a non‐wearable monitor |
title_fullStr | The change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: Continuous measurement of vital signs using a non‐wearable monitor |
title_full_unstemmed | The change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: Continuous measurement of vital signs using a non‐wearable monitor |
title_short | The change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: Continuous measurement of vital signs using a non‐wearable monitor |
title_sort | change over time of vital signs with consideration for opioid use in the last 2 weeks of life among cancer patients in a palliative care unit: continuous measurement of vital signs using a non‐wearable monitor |
topic | Clinical Cancer Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683542/ https://www.ncbi.nlm.nih.gov/pubmed/34845870 http://dx.doi.org/10.1002/cam4.4382 |
work_keys_str_mv | AT tanakaharuka thechangeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor AT fukuisakiko thechangeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor AT maedaisseki thechangeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor AT hatanoyutaka thechangeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor AT higuchiakari thechangeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor AT higamiyoko thechangeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor AT yamakawamiyae thechangeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor AT utsumimomoe thechangeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor AT tanakaharuka changeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor AT fukuisakiko changeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor AT maedaisseki changeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor AT hatanoyutaka changeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor AT higuchiakari changeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor AT higamiyoko changeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor AT yamakawamiyae changeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor AT utsumimomoe changeovertimeofvitalsignswithconsiderationforopioiduseinthelast2weeksoflifeamongcancerpatientsinapalliativecareunitcontinuousmeasurementofvitalsignsusinganonwearablemonitor |